vs

Side-by-side financial comparison of TANDEM DIABETES CARE INC (TNDM) and VIRTUS INVESTMENT PARTNERS, INC. (VRTS). Click either name above to swap in a different company.

TANDEM DIABETES CARE INC is the larger business by last-quarter revenue ($290.4M vs $199.5M, roughly 1.5× VIRTUS INVESTMENT PARTNERS, INC.). VIRTUS INVESTMENT PARTNERS, INC. runs the higher net margin — 3.6% vs -0.2%, a 3.8% gap on every dollar of revenue. On growth, TANDEM DIABETES CARE INC posted the faster year-over-year revenue change (2.7% vs -4.1%). Over the past eight quarters, TANDEM DIABETES CARE INC's revenue compounded faster (23.1% CAGR vs -5.7%).

Tandem Diabetes Care, Inc. is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.

Virtus Investment Partners, Inc. is an American company which operates as a multi-manager asset management business, comprising a number of individual affiliated managers, each having its own investment process and brand, and the services of unaffiliated sub advisers.

TNDM vs VRTS — Head-to-Head

Bigger by revenue
TNDM
TNDM
1.5× larger
TNDM
$290.4M
$199.5M
VRTS
Growing faster (revenue YoY)
TNDM
TNDM
+6.8% gap
TNDM
2.7%
-4.1%
VRTS
Higher net margin
VRTS
VRTS
3.8% more per $
VRTS
3.6%
-0.2%
TNDM
Faster 2-yr revenue CAGR
TNDM
TNDM
Annualised
TNDM
23.1%
-5.7%
VRTS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
TNDM
TNDM
VRTS
VRTS
Revenue
$290.4M
$199.5M
Net Profit
$-589.0K
$7.1M
Gross Margin
57.7%
Operating Margin
2.9%
7.7%
Net Margin
-0.2%
3.6%
Revenue YoY
2.7%
-4.1%
Net Profit YoY
-178.0%
-78.1%
EPS (diluted)
$0.02
$1.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TNDM
TNDM
VRTS
VRTS
Q1 26
$199.5M
Q4 25
$290.4M
$208.0M
Q3 25
$249.3M
$216.4M
Q2 25
$240.7M
$210.5M
Q1 25
$234.4M
$217.9M
Q4 24
$282.6M
$233.5M
Q3 24
$244.0M
$227.0M
Q2 24
$221.9M
$224.4M
Net Profit
TNDM
TNDM
VRTS
VRTS
Q1 26
$7.1M
Q4 25
$-589.0K
$33.9M
Q3 25
$-21.2M
$31.3M
Q2 25
$-52.4M
$42.7M
Q1 25
$-130.6M
$28.1M
Q4 24
$755.0K
$39.5M
Q3 24
$-23.3M
$49.1M
Q2 24
$-30.8M
$26.0M
Gross Margin
TNDM
TNDM
VRTS
VRTS
Q1 26
Q4 25
57.7%
Q3 25
53.9%
Q2 25
52.3%
Q1 25
50.5%
Q4 24
55.7%
Q3 24
51.1%
Q2 24
50.8%
Operating Margin
TNDM
TNDM
VRTS
VRTS
Q1 26
7.7%
Q4 25
2.9%
19.1%
Q3 25
-9.2%
21.7%
Q2 25
-21.5%
21.5%
Q1 25
-51.6%
16.8%
Q4 24
-0.2%
21.7%
Q3 24
-10.7%
24.3%
Q2 24
-13.9%
19.7%
Net Margin
TNDM
TNDM
VRTS
VRTS
Q1 26
3.6%
Q4 25
-0.2%
16.3%
Q3 25
-8.5%
14.5%
Q2 25
-21.8%
20.3%
Q1 25
-55.7%
12.9%
Q4 24
0.3%
16.9%
Q3 24
-9.5%
21.6%
Q2 24
-13.9%
11.6%
EPS (diluted)
TNDM
TNDM
VRTS
VRTS
Q1 26
$1.05
Q4 25
$0.02
$5.15
Q3 25
$-0.31
$4.65
Q2 25
$-0.78
$6.12
Q1 25
$-1.97
$4.05
Q4 24
$0.00
$4.65
Q3 24
$-0.35
$5.71
Q2 24
$-0.47
$2.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TNDM
TNDM
VRTS
VRTS
Cash + ST InvestmentsLiquidity on hand
$292.7M
$136.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$155.2M
$93.6B
Total Assets
$881.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TNDM
TNDM
VRTS
VRTS
Q1 26
$136.6M
Q4 25
$292.7M
Q3 25
$319.1M
Q2 25
$315.4M
Q1 25
$368.6M
Q4 24
$438.3M
Q3 24
$473.3M
Q2 24
$452.4M
Total Debt
TNDM
TNDM
VRTS
VRTS
Q1 26
Q4 25
$390.0M
Q3 25
$390.6M
Q2 25
$231.3M
Q1 25
$231.7M
Q4 24
$232.1M
Q3 24
$237.5M
Q2 24
$247.6M
Stockholders' Equity
TNDM
TNDM
VRTS
VRTS
Q1 26
$93.6B
Q4 25
$155.2M
$934.0M
Q3 25
$133.0M
$918.7M
Q2 25
$133.3M
$896.4M
Q1 25
$155.3M
$893.7M
Q4 24
$263.1M
$897.5M
Q3 24
$237.7M
$889.0M
Q2 24
$233.9M
$868.7M
Total Assets
TNDM
TNDM
VRTS
VRTS
Q1 26
Q4 25
$881.1M
$4.3B
Q3 25
$874.7M
$3.9B
Q2 25
$875.7M
$3.7B
Q1 25
$922.1M
$3.7B
Q4 24
$967.7M
$4.0B
Q3 24
$957.7M
$3.6B
Q2 24
$937.5M
$3.6B
Debt / Equity
TNDM
TNDM
VRTS
VRTS
Q1 26
Q4 25
0.42×
Q3 25
0.43×
Q2 25
0.26×
Q1 25
0.26×
Q4 24
0.26×
Q3 24
0.27×
Q2 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TNDM
TNDM
VRTS
VRTS
Operating Cash FlowLast quarter
$9.8M
Free Cash FlowOCF − Capex
$3.1M
FCF MarginFCF / Revenue
1.1%
Capex IntensityCapex / Revenue
2.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-29.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TNDM
TNDM
VRTS
VRTS
Q1 26
Q4 25
$9.8M
$-67.2M
Q3 25
$8.3M
$108.3M
Q2 25
$-9.5M
$75.8M
Q1 25
$-18.3M
$-3.8M
Q4 24
$10.7M
$1.8M
Q3 24
$26.8M
$69.1M
Q2 24
$-5.3M
$70.0M
Free Cash Flow
TNDM
TNDM
VRTS
VRTS
Q1 26
Q4 25
$3.1M
$-74.1M
Q3 25
$4.2M
$106.9M
Q2 25
$-15.7M
$74.2M
Q1 25
$-21.2M
$-6.8M
Q4 24
$7.6M
$-3.8M
Q3 24
$21.5M
$68.7M
Q2 24
$-11.7M
$68.6M
FCF Margin
TNDM
TNDM
VRTS
VRTS
Q1 26
Q4 25
1.1%
-35.6%
Q3 25
1.7%
49.4%
Q2 25
-6.5%
35.2%
Q1 25
-9.1%
-3.1%
Q4 24
2.7%
-1.6%
Q3 24
8.8%
30.3%
Q2 24
-5.3%
30.6%
Capex Intensity
TNDM
TNDM
VRTS
VRTS
Q1 26
Q4 25
2.3%
3.3%
Q3 25
1.6%
0.7%
Q2 25
2.6%
0.7%
Q1 25
1.3%
1.4%
Q4 24
1.1%
2.4%
Q3 24
2.1%
0.2%
Q2 24
2.9%
0.6%
Cash Conversion
TNDM
TNDM
VRTS
VRTS
Q1 26
Q4 25
-1.99×
Q3 25
3.45×
Q2 25
1.77×
Q1 25
-0.13×
Q4 24
14.19×
0.04×
Q3 24
1.41×
Q2 24
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TNDM
TNDM

Supplies And Other$150.3M52%
Pump$140.1M48%

VRTS
VRTS

Investment management fees$169.1M85%
Administration and shareholder service fees$17.3M9%
Distribution and service fees$11.6M6%

Related Comparisons